Curative Biosciences, Inc.
CBDX
$0.0001
$0.000.00%
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.00K | -- | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.00K | -- | -- | -- | -- |
|
|
|||||
| Total Current Assets | 1.00K | -- | -- | -- | -- |
| Net Property, Plant & Equipment | 400.00 | 800.00 | 1.60K | 2.30K | 3.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 12.50K | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 13.90K | 800.00 | 1.60K | 2.30K | 3.00K |
|
|
|||||
| Total Accounts Payable | 170.20K | 170.20K | 175.70K | 177.40K | 161.90K |
| Total Accrued Expenses | 10.10K | 10.10K | 10.10K | 10.10K | 10.10K |
| Short-term Debt | 156.50K | 111.40K | 80.50K | 62.80K | 61.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 382.70K | 382.70K | 382.70K | 382.70K | 382.70K |
| Total Other Current Liabilities | 382.70K | 382.70K | 382.70K | 382.70K | 382.70K |
| Total Current Liabilities | 719.50K | 674.50K | 649.10K | 633.10K | 615.90K |
|
|
|||||
| Total Current Liabilities | 719.50K | 674.50K | 649.10K | 633.10K | 615.90K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 156.50K | 111.40K | 80.50K | 62.80K | 61.10K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 719.50K | 674.50K | 649.10K | 633.10K | 615.90K |
|
|
|||||
| Common Stock & APIC | 52.96M | 52.96M | 52.53M | 52.53M | 52.53M |
| Retained Earnings | -53.66M | -53.63M | -53.18M | -53.16M | -53.14M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -705.70K | -673.70K | -647.50K | -630.80K | -612.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -705.70K | -673.70K | -647.50K | -630.80K | -612.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -705.70K | -673.70K | -647.50K | -630.80K | -612.90K |
|
|
|||||
